{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:02:46Z","timestamp":1792713766769,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Co-inhibitory pathways have a fundamental function in regulating T cell responses and control the balance between promoting efficient effector functions and restricting immune pathology. The TIGIT pathway has been implicated in promoting T cell dysfunction in chronic viral infection. Importantly, TIGIT signaling is functionally linked to IL-10 expression, which has an effect on both virus control and maintenance of tissue homeostasis. However, whether TIGIT has a function in viral persistence or limiting tissue pathology is unclear. Here we report that TIGIT modulation effectively alters the phenotype and cytokine profile of T cells during influenza and chronic LCMV infection, but does not affect virus control in vivo. Instead, TIGIT has an important effect in limiting immune pathology in peripheral organs by inducing IL-10. Our data therefore identify a function of TIGIT in limiting immune pathology that is independent of viral clearance.<\/jats:p>","DOI":"10.1038\/s41467-020-15025-1","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T11:02:46Z","timestamp":1583751766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["TIGIT limits immune pathology during viral infections"],"prefix":"10.1038","volume":"11","author":[{"given":"Michelle","family":"Schorer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas","family":"Rakebrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1998-0024","authenticated-orcid":false,"given":"Katharina","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Hunziker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Pallmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2079-2354","authenticated-orcid":false,"given":"Annette","family":"Oxenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7289-3459","authenticated-orcid":false,"given":"Anja","family":"Kipar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Stertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1996-1672","authenticated-orcid":false,"given":"Nicole","family":"Joller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,9]]},"reference":[{"key":"15025_CR1","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","volume":"188","author":"AJ Zajac","year":"1998","unstructured":"Zajac, A. J. et al. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188, 2205\u20132213 (1998).","journal-title":"J. Exp. Med."},{"key":"15025_CR2","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","volume":"77","author":"EJ Wherry","year":"2003","unstructured":"Wherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most, R. & Ahmed, R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77, 4911\u20134927 (2003).","journal-title":"J. Virol."},{"key":"15025_CR3","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/362758a0","volume":"362","author":"D Moskophidis","year":"1993","unstructured":"Moskophidis, D., Lechner, F., Pircher, H. & Zinkernagel, R. M. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362, 758\u2013761 (1993).","journal-title":"Nature"},{"key":"15025_CR4","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1084\/jem.187.9.1383","volume":"187","author":"A Gallimore","year":"1998","unstructured":"Gallimore, A. et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187, 1383\u20131393 (1998).","journal-title":"J. Exp. Med."},{"key":"15025_CR5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486\u2013499 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"15025_CR6","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.jhep.2006.07.026","volume":"45","author":"M Persico","year":"2006","unstructured":"Persico, M. et al. Interleukin-10 - 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection. J. Hepatol. 45, 779\u2013785 (2006).","journal-title":"J. Hepatol."},{"key":"15025_CR7","doi-asserted-by":"publisher","first-page":"9144","DOI":"10.1128\/JVI.00339-06","volume":"80","author":"N Paladino","year":"2006","unstructured":"Paladino, N. et al. Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism. J. Virol. 80, 9144\u20139150 (2006).","journal-title":"J. Virol."},{"key":"15025_CR8","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.ccell.2014.10.018","volume":"26","author":"RJ Johnston","year":"2014","unstructured":"Johnston, R. J. et al. The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function. Cancer Cell 26, 923\u2013937 (2014).","journal-title":"Cancer Cell"},{"key":"15025_CR9","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.4049\/jimmunol.1003081","volume":"186","author":"N Joller","year":"2011","unstructured":"Joller, N. et al. Cutting edge: TIGIT has T cell-intrinsic inhibitory functions. J. Immunol. 186, 1338\u20131342 (2011).","journal-title":"J. Immunol."},{"key":"15025_CR10","doi-asserted-by":"publisher","first-page":"17858","DOI":"10.1073\/pnas.0903474106","volume":"106","author":"N Stanietsky","year":"2009","unstructured":"Stanietsky, N. et al. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc. Natl Acad. Sci. USA 106, 17858\u201317863 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"15025_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/ni.1674","volume":"10","author":"X Yu","year":"2009","unstructured":"Yu, X. et al. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat. Immunol. 10, 48\u201357 (2009).","journal-title":"Nat. Immunol."},{"key":"15025_CR12","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/j.1349-7006.2010.01530.x","volume":"101","author":"R Nakai","year":"2010","unstructured":"Nakai, R. et al. Overexpression of Necl-5 correlates with unfavorable prognosis in patients with lung adenocarcinoma. Cancer Sci. 101, 1326\u20131330 (2010).","journal-title":"Cancer Sci."},{"key":"15025_CR13","first-page":"2287","volume":"35","author":"S Nishiwada","year":"2015","unstructured":"Nishiwada, S. et al. Clinical significance of CD155 expression in human pancreatic cancer. Anticancer Res. 35, 2287\u20132297 (2015).","journal-title":"Anticancer Res."},{"key":"15025_CR14","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.4049\/jimmunol.1103627","volume":"188","author":"E Lozano","year":"2012","unstructured":"Lozano, E., Dominguez-Villar, M., Kuchroo, V. & Hafler, D. A. The TIGIT\/CD226 axis regulates human T cell function. J. Immunol. 188, 3869\u20133875 (2012).","journal-title":"J. Immunol."},{"key":"15025_CR15","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/eji.201041136","volume":"41","author":"SD Levin","year":"2011","unstructured":"Levin, S. D. et al. Vstm3 is a member of the CD28 family and an important modulator of T-cell function. Eur. J. Immunol. 41, 902\u2013915 (2011).","journal-title":"Eur. J. Immunol."},{"key":"15025_CR16","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.immuni.2014.02.012","volume":"40","author":"N Joller","year":"2014","unstructured":"Joller, N. et al. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity 40, 569\u2013581 (2014).","journal-title":"Immunity"},{"key":"15025_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.immuni.2018.01.006","volume":"48","author":"LK Smith","year":"2018","unstructured":"Smith, L. K. et al. Interleukin-10 directly inhibits CD8(+) T cell function by enhancing N-glycan branching to decrease antigen sensitivity. Immunity 48, 299\u2013312 e295 (2018).","journal-title":"Immunity"},{"key":"15025_CR18","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1172\/JCI66108","volume":"124","author":"IA Parish","year":"2014","unstructured":"Parish, I. A. et al. Chronic viral infection promotes sustained Th1-derived immunoregulatory IL-10 via BLIMP-1. J. Clin. Invest. 124, 3455\u20133468 (2014).","journal-title":"J. Clin. Invest."},{"key":"15025_CR19","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1084\/jem.20061462","volume":"203","author":"M Ejrnaes","year":"2006","unstructured":"Ejrnaes, M. et al. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203, 2461\u20132472 (2006).","journal-title":"J. Exp. Med."},{"key":"15025_CR20","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.4049\/jimmunol.1100764","volume":"187","author":"KA Weiss","year":"2011","unstructured":"Weiss, K. A., Christiaansen, A. F., Fulton, R. B., Meyerholz, D. K. & Varga, S. M. Multiple CD4+ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection. J. Immunol. 187, 3145\u20133154 (2011).","journal-title":"J. Immunol."},{"key":"15025_CR21","doi-asserted-by":"publisher","first-page":"e1005398","DOI":"10.1371\/journal.ppat.1005398","volume":"12","author":"M Montes de Oca","year":"2016","unstructured":"Montes de Oca, M. et al. Blimp-1-dependent IL-10 production by Tr1 cells regulates TNF-mediated tissue pathology. PLoS Pathog. 12, e1005398 (2016).","journal-title":"PLoS Pathog."},{"key":"15025_CR22","doi-asserted-by":"publisher","first-page":"6104054","DOI":"10.1155\/2017\/6104054","volume":"2017","author":"JM Rojas","year":"2017","unstructured":"Rojas, J. M., Avia, M., Martin, V. & Sevilla, N. IL-10: a multifunctional cytokine in viral infections. J. Immunol. Res. 2017, 6104054 (2017).","journal-title":"J. Immunol. Res."},{"key":"15025_CR23","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.4049\/jimmunol.158.7.3311","volume":"158","author":"CA Hunter","year":"1997","unstructured":"Hunter, C. A. et al. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158, 3311\u20133316 (1997).","journal-title":"J. Immunol."},{"key":"15025_CR24","doi-asserted-by":"crossref","first-page":"798","DOI":"10.4049\/jimmunol.157.2.798","volume":"157","author":"RT Gazzinelli","year":"1996","unstructured":"Gazzinelli, R. T. et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 157, 798\u2013805 (1996).","journal-title":"J. Immunol."},{"key":"15025_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08096-8","volume":"10","author":"L Zong","year":"2019","unstructured":"Zong, L. et al. Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice. Nat. Commun. 10, 221 (2019).","journal-title":"Nat. Commun."},{"key":"15025_CR26","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/hep.27245","volume":"60","author":"J Bi","year":"2014","unstructured":"Bi, J. et al. TIGIT safeguards liver regeneration through regulating natural killer cell-hepatocyte crosstalk. Hepatology 60, 1389\u20131398 (2014).","journal-title":"Hepatology"},{"key":"15025_CR27","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.immuni.2011.06.015","volume":"35","author":"B Youngblood","year":"2011","unstructured":"Youngblood, B. et al. Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells. Immunity 35, 400\u2013412 (2011).","journal-title":"Immunity"},{"key":"15025_CR28","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.coi.2007.06.004","volume":"19","author":"H Shin","year":"2007","unstructured":"Shin, H. & Wherry, E. J. CD8 T cell dysfunction during chronic viral infection. Curr. Opin. Immunol. 19, 408\u2013415 (2007).","journal-title":"Curr. Opin. Immunol."},{"key":"15025_CR29","doi-asserted-by":"publisher","first-page":"e1003735","DOI":"10.1371\/journal.ppat.1003735","volume":"9","author":"K Richter","year":"2013","unstructured":"Richter, K. et al. Macrophage and T cell produced IL-10 promotes viral chronicity. PLoS Pathog. 9, e1003735 (2013).","journal-title":"PLoS Pathog."},{"key":"15025_CR30","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/ni1504","volume":"8","author":"CL Maynard","year":"2007","unstructured":"Maynard, C. L. et al. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat. Immunol. 8, 931\u2013941 (2007).","journal-title":"Nat. Immunol."},{"key":"15025_CR31","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.4049\/jimmunol.1700407","volume":"200","author":"KO Dixon","year":"2018","unstructured":"Dixon, K. O. et al. Functional anti-TIGIT antibodies regulate development of autoimmunity and antitumor immunity. J. Immunol. 200, 3000\u20133007 (2018).","journal-title":"J. Immunol."},{"key":"15025_CR32","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/nm1492","volume":"12","author":"DG Brooks","year":"2006","unstructured":"Brooks, D. G. et al. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12, 1301\u20131309 (2006).","journal-title":"Nat. Med."},{"key":"15025_CR33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.4049\/jimmunol.170.1.477","volume":"170","author":"MJ Fuller","year":"2003","unstructured":"Fuller, M. J. & Zajac, A. J. Ablation of CD8 and CD4 T cell responses by high viral loads. J. Immunol. 170, 477\u2013486 (2003).","journal-title":"J. Immunol."},{"key":"15025_CR34","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1002\/eji.1830231237","volume":"23","author":"D Moskophidis","year":"1993","unstructured":"Moskophidis, D., Laine, E. & Zinkernagel, R. M. Peripheral clonal deletion of antiviral memory CD8+ T cells. Eur. J. Immunol. 23, 3306\u20133311 (1993).","journal-title":"Eur. J. Immunol."},{"key":"15025_CR35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","volume":"45","author":"DT Utzschneider","year":"2016","unstructured":"Utzschneider, D. T. et al. T cell factor 1-expressing memory-like CD8(+) T cells sustain the immune response to chronic viral infections. Immunity 45, 415\u2013427 (2016).","journal-title":"Immunity"},{"key":"15025_CR36","doi-asserted-by":"publisher","first-page":"6822","DOI":"10.1128\/JVI.00510-11","volume":"85","author":"K Trandem","year":"2011","unstructured":"Trandem, K. et al. Virally expressed interleukin-10 ameliorates acute encephalomyelitis and chronic demyelination in coronavirus-infected mice. J. Virol. 85, 6822\u20136831 (2011).","journal-title":"J. Virol."},{"key":"15025_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8055","volume":"6","author":"P Krause","year":"2015","unstructured":"Krause, P. et al. IL-10-producing intestinal macrophages prevent excessive antibacterial innate immunity by limiting IL-23 synthesis. Nat. Commun. 6, 7055 (2015).","journal-title":"Nat. Commun."},{"key":"15025_CR38","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.161.7.3299","volume":"161","author":"E Bettelli","year":"1998","unstructured":"Bettelli, E. et al. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161, 3299\u20133306 (1998).","journal-title":"J. Immunol."},{"key":"15025_CR39","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1084\/jem.164.4.1075","volume":"164","author":"RM Zinkernagel","year":"1986","unstructured":"Zinkernagel, R. M. et al. T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay? J. Exp. Med. 164, 1075\u20131092 (1986).","journal-title":"J. Exp. Med."},{"key":"15025_CR40","first-page":"817","volume":"15","author":"MR McGill","year":"2016","unstructured":"McGill, M. R. The past and present of serum aminotransferases and the future of liver injury biomarkers. EXCLI J. 15, 817\u2013828 (2016).","journal-title":"EXCLI J."},{"key":"15025_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07213-x","volume":"9","author":"M Welz","year":"2018","unstructured":"Welz, M. et al. Perforin inhibition protects from lethal endothelial damage during fulminant viral hepatitis. Nat. Commun. 9, 4805 (2018).","journal-title":"Nat. Commun."},{"key":"15025_CR42","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1084\/jem.20121015","volume":"209","author":"H Frebel","year":"2012","unstructured":"Frebel, H. et al. Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice. J. Exp. Med. 209, 2485\u20132499 (2012).","journal-title":"J. Exp. Med."},{"key":"15025_CR43","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.immuni.2012.08.021","volume":"37","author":"TA Doering","year":"2012","unstructured":"Doering, T. A. et al. Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory. Immunity 37, 1130\u20131144 (2012).","journal-title":"Immunity"},{"key":"15025_CR44","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1128\/JVI.68.7.4700-4704.1994","volume":"68","author":"M Battegay","year":"1994","unstructured":"Battegay, M. et al. Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. J. Virol. 68, 4700\u20134704 (1994).","journal-title":"J. Virol."},{"key":"15025_CR45","doi-asserted-by":"publisher","first-page":"8056","DOI":"10.1128\/JVI.68.12.8056-8063.1994","volume":"68","author":"M Matloubian","year":"1994","unstructured":"Matloubian, M., Concepcion, R. J. & Ahmed, R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J. Virol. 68, 8056\u20138063 (1994).","journal-title":"J. Virol."},{"key":"15025_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5741","volume":"5","author":"BR Burton","year":"2014","unstructured":"Burton, B. R. et al. Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy. Nat. Commun. 5, 4741 (2014).","journal-title":"Nat. Commun."},{"key":"15025_CR47","doi-asserted-by":"publisher","first-page":"e1005349","DOI":"10.1371\/journal.ppat.1005349","volume":"12","author":"GM Chew","year":"2016","unstructured":"Chew, G. M. et al. TIGIT marks exhausted T cells, correlates with disease progression, and serves as a target for immune restoration in HIV and SIV infection. PLoS Pathog. 12, e1005349 (2016).","journal-title":"PLoS Pathog."},{"key":"15025_CR48","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nm0295-129","volume":"1","author":"TH Finkel","year":"1995","unstructured":"Finkel, T. H. et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 1, 129\u2013134 (1995).","journal-title":"Nat. Med."},{"key":"15025_CR49","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1749-6632.1999.tb07934.x","volume":"887","author":"ML Gougeon","year":"1999","unstructured":"Gougeon, M. L. & Montagnier, L. Programmed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS. Molecular control and effect of highly active anti-retroviral therapy. Ann. N. Y. Acad. Sci. 887, 199\u2013212 (1999).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"15025_CR50","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1073\/pnas.1712107115","volume":"115","author":"L Avery","year":"2018","unstructured":"Avery, L., Filderman, J., Szymczak-Workman, A. L. & Kane, L. P. Tim-3 co-stimulation promotes short-lived effector T cells, restricts memory precursors, and is dispensable for T cell exhaustion. Proc. Natl Acad. Sci. USA 115, 2455\u20132460 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"15025_CR51","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/intimm\/dxp107","volume":"22","author":"K Richter","year":"2010","unstructured":"Richter, K., Agnellini, P. & Oxenius, A. On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection. Int. Immunol. 22, 13\u201323 (2010).","journal-title":"Int. Immunol."},{"key":"15025_CR52","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682\u2013687 (2006).","journal-title":"Nature"},{"key":"15025_CR53","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jhep.2007.12.014","volume":"48","author":"S Urbani","year":"2008","unstructured":"Urbani, S. et al. Restoration of HCV-specific T cell functions by PD-1\/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. J. Hepatol. 48, 548\u2013558 (2008).","journal-title":"J. Hepatol."},{"key":"15025_CR54","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1172\/JCI40040","volume":"120","author":"SN Mueller","year":"2010","unstructured":"Mueller, S. N. et al. PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating T cell responses during chronic infection in mice. J. Clin. Invest. 120, 2508\u20132515 (2010).","journal-title":"J. Clin. Invest."},{"key":"15025_CR55","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/cdd.2014.19","volume":"21","author":"M Grusdat","year":"2014","unstructured":"Grusdat, M. et al. IRF4 and BATF are critical for CD8(+) T-cell function following infection with LCMV. Cell Death Differ. 21, 1050\u20131060 (2014).","journal-title":"Cell Death Differ."},{"key":"15025_CR56","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1084\/jem.190.7.995","volume":"190","author":"C Asseman","year":"1999","unstructured":"Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L. & Powrie, F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190, 995\u20131004 (1999).","journal-title":"J. Exp. Med."},{"key":"15025_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0656-x","volume":"13","author":"JH Kim","year":"2016","unstructured":"Kim, J. H. et al. CCR5 ameliorates Japanese encephalitis via dictating the equilibrium of regulatory CD4(+)Foxp3(+) T and IL-17(+)CD4(+) Th17 cells. J. Neuroinflammation 13, 223 (2016).","journal-title":"J. Neuroinflammation"},{"key":"15025_CR58","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.4049\/jimmunol.1003292","volume":"186","author":"K Trandem","year":"2011","unstructured":"Trandem, K., Zhao, J., Fleming, E. & Perlman, S. Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis. J. Immunol. 186, 3642\u20133652 (2011).","journal-title":"J. Immunol."},{"key":"15025_CR59","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nm.1929","volume":"15","author":"J Sun","year":"2009","unstructured":"Sun, J., Madan, R., Karp, C. L. & Braciale, T. J. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 15, 277\u2013284 (2009).","journal-title":"Nat. Med."},{"key":"15025_CR60","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4049\/jimmunol.1701406","volume":"201","author":"D Califano","year":"2018","unstructured":"Califano, D., Furuya, Y. & Metzger, D. W. Effects of influenza on alveolar macrophage viability are dependent on mouse genetic strain. J. Immunol. 201, 134\u2013144 (2018).","journal-title":"J. Immunol."},{"key":"15025_CR61","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.4049\/jimmunol.149.10.3129","volume":"149","author":"HC Morse 3rd","year":"1992","unstructured":"Morse, H. C. 3rd Genetic nomenclature for loci controlling surface antigens of mouse hemopoietic cells. J. Immunol. 149, 3129\u20133134 (1992).","journal-title":"J. Immunol."},{"key":"15025_CR62","volume-title":"Cell Surface Antigens: Studies in Mammals Other Than Man","author":"GD Snell","year":"1973","unstructured":"Snell, G. D. Cell Surface Antigens: Studies in Mammals Other Than Man (MSS Information Corp, New York, 1973)."},{"key":"15025_CR63","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235\u2013238 (2006).","journal-title":"Nature"},{"key":"15025_CR64","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/346629a0","volume":"346","author":"H Pircher","year":"1990","unstructured":"Pircher, H. et al. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346, 629\u2013633 (1990).","journal-title":"Nature"},{"key":"15025_CR65","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O","volume":"28","author":"A Oxenius","year":"1998","unstructured":"Oxenius, A., Bachmann, M. F., Zinkernagel, R. M. & Hengartner, H. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 28, 390\u2013400 (1998).","journal-title":"Eur. J. Immunol."},{"key":"15025_CR66","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","volume":"75","author":"R Kuhn","year":"1993","unstructured":"Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. & Muller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263\u2013274 (1993).","journal-title":"Cell"},{"key":"15025_CR67","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1126\/science.274.5284.94","volume":"274","author":"JD Altman","year":"1996","unstructured":"Altman, J. D. et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94\u201396 (1996).","journal-title":"Science"},{"key":"15025_CR68","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0166-0934(91)90018-U","volume":"33","author":"M Battegay","year":"1991","unstructured":"Battegay, M. et al. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J. Virol. Methods 33, 191\u2013198 (1991).","journal-title":"J. Virol. Methods"},{"key":"15025_CR69","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak, K. et al. Histological grading and staging of chronic hepatitis. J. Hepatol. 22, 696\u2013699 (1995).","journal-title":"J. Hepatol."},{"issue":"7_suppl","key":"15025_CR70","doi-asserted-by":"publisher","first-page":"5S","DOI":"10.1177\/0192623310386499","volume":"38","author":"Bob Thoolen","year":"2010","unstructured":"Thoolen, B. et al. Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system. Toxicol. Pathol. 38, 5S\u201381S (2010).","journal-title":"Toxicologic Pathology"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15025-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15025-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15025-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T10:08:31Z","timestamp":1695895711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15025-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,9]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["15025"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-15025-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,9]]},"assertion":[{"value":"7 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1288"}}